LECANEMAB AUTOINJECTOR
NDC 62856-220, lecanemab-irmb, injection, solution, from Eisai Inc..
- Product NDC
- 62856-220
- Status
- Listed
- Labeler
- Eisai Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761375
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62856-220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LECANEMAB-IRMB200 mg/mL
Pharmacologic classes
Amyloid Beta-directed Antibody Interactions [MoA]; Amyloid Beta-directed Antibody [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62856-220-01 | 62856022001 | 1 SYRINGE, PLASTIC in 1 CARTON (62856-220-01) / 1.8 mL in 1 SYRINGE, PLASTIC (62856-220-10) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9d1ff786-e577-410a-a273-c4d7d0e4e975
Use it
Look up 62856-220 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62856-220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62856-220. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.